<DOC>
	<DOCNO>NCT01292252</DOCNO>
	<brief_summary>The purpose study determine effect 12 week daily treatment teriparatide spine fusion adult patient undergo multi-level posterolateral spine fusion surgery degenerative condition lumbar spine .</brief_summary>
	<brief_title>Use Forteo ( Teriparatide ) Posterolateral Lumbar Spine Fusion</brief_title>
	<detailed_description>For patient undergoing spine fusion surgery , non-fusion ( pseudarthrosis ) one major complication lead poor clinical outcome . Therefore , treatment promote augment fusion highly desirable . Teriparatide ( Forteo , recombinant human parathyroid hormone [ 1-34 ] ) systemically administer peptide hormone FDA-approved treatment osteoporosis postmenopausal woman population high risk fracture . While teriparatide show enhance spinal fusion several rodent rabbit study , clinical study date examine effect spinal fusion human . This single-site two-year prospective randomize double-blind placebo-controlled study design examine effect peri-operative teriparatide treatment old adult undergo multi-level posterolateral lumbar spine fusion . All eligible patient see UCSF Spine Center invite enroll study . Upon enrollment , patient screen labs drawn conjunction routine pre-operative work-up , include complete blood count ( CBC ) , chemistry panel include calcium level , liver function test ( LFTs ) include alkaline phosphatase , parathyroid hormone ( PTH ) level , 25-hydroxyvitamin D level . If eligible screening lab complete , schedule bone density ( DEXA ) scan randomize 2:1 ratio receive daily subcutaneous injection teriparatide 20 ug/d placebo . The total duration treatment 12 week , two week pre-operative 10 week post-operative treatment . Patients schedule attend standard post-operative follow-up clinic visit , 6 week , 3 month , 6 month , 12 month surgery . At 3 month post operative visit , patient lab drawn calcium . At follow-up visit , AP lateral x-ray radiograph take lumber spine ass progression bone heal position hardware place . Participants ask complete pain Visual Analog Score ( VAS ) , European Quality Life-5 Dimensions ( EQ-5D ) , Oswestry Disability Index ( ODI ) questionnaire visit assessment clinical outcome . Thin-section helical CT scan lumbar spine take 12 month surgery definitive assessment fusion . All radiograph evaluate blinded panel three reviewer include radiologist spine surgeon assess primary outcome .</detailed_description>
	<mesh_term>Scoliosis</mesh_term>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spondylosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Patients age 6090 year lumbar spondylosis , spondylolithesis , adult degenerative scoliosis , include disc pathology , stenosis , deformity , instability , postdecompression revision , schedule undergo threelevel great posterolateral lumbar spinal fusion . Willing able use pentype delivery system administer daily subcutaneous injection . Use bone morphogenic protein ( BMP ) posterolaterally fusion procedure . Previous spinal fusion intend fusion level . Prior use Forteo ( teriparatide ) . Use digoxin . Paget 's Disease bone . History primary skeletal malignancy , presence bone metastasis , previous skeletal exposure therapeutic irradiation . Elevated serum calcium , serum PTH &gt; 70 pg/ml , 25hydroxyvitamin D &lt; 12 ng/mL , active liver disease . History symptomatic nephro urolithiasis past two year . History malignant neoplasm past five year , except superficial basal cell carcinoma squamous cell carcinoma . Carcinoma situ uterine cervix treat past year .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>